Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lattuada

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
International Journal of Radiation Oncology, Biology, Physics|February 1, 1980
Improved five year survival after combined radiotherapy-chemotherapy for stage I-II non-Hodgkin's lymphomaS Monfardini, A Banfi, G Bonadonna, et al.
Hepatology (Baltimore, Md.)|June 1, 1996
High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: relationship to endotoxemiaD Ferro, C Quintarelli, A Lattuada, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 1989
Advanced neuroblastoma: results of two treatment programs including sequential hemibody irradiationF Lombardi, L Rottoli, C Gianni, et al.
Italian Journal of Gastroenterology and Hepatology|March 12, 1998
Systemic clotting activation by low-grade endotoxaemia in liver cirrhosis: a potential role for endothelial procoagulant activationD Ferro, S Basili, A Lattuada, et al.
British Journal of Haematology|March 1, 1996
Proteolysis of von Willebrand factor is decreased in acute promyelocytic leukaemia by treatment with all-trans-retinoic acidA B Federici, A Falanga, A Lattuada, et al.
Blood|November 15, 1989
Heterogeneous phenotypes of platelet and plasma von Willebrand factor in obligatory heterozygotes for severe von Willebrand diseaseP M Mannucci, A Lattuada, G Castaman, et al.
Blood|August 15, 1989
Enhanced proteolysis of plasma von Willebrand factor in thrombotic thrombocytopenic purpura and the hemolytic uremic syndromeP M Mannucci, R Lombardi, A Lattuada, et al.
Circulation|September 12, 2000
Proteolysis of von Willebrand factor and shear stress-induced platelet aggregation in patients with aortic valve stenosisF I Pareti, A Lattuada, C Bressi, et al.
Blood|January 1, 1988
von Willebrand disease "Vicenza" with larger-than-normal (supranormal) von Willebrand factor multimersP M Mannucci, R Lombardi, G Castaman, et al.
HSR Proceedings in Intensive Care & Cardiovascular Anesthesia|February 27, 2013
Perioperative evaluation of primary hemostasis in patients undergoing mitral valve repairF Pappalardo, P Della Valle, G Maj, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
International Journal of Radiation Oncology, Biology, Physics|February 1, 1980
Improved five year survival after combined radiotherapy-chemotherapy for stage I-II non-Hodgkin's lymphomaS Monfardini, A Banfi, G Bonadonna, et al.
Hepatology (Baltimore, Md.)|June 1, 1996
High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: relationship to endotoxemiaD Ferro, C Quintarelli, A Lattuada, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 1989
Advanced neuroblastoma: results of two treatment programs including sequential hemibody irradiationF Lombardi, L Rottoli, C Gianni, et al.
Italian Journal of Gastroenterology and Hepatology|March 12, 1998
Systemic clotting activation by low-grade endotoxaemia in liver cirrhosis: a potential role for endothelial procoagulant activationD Ferro, S Basili, A Lattuada, et al.
British Journal of Haematology|March 1, 1996
Proteolysis of von Willebrand factor is decreased in acute promyelocytic leukaemia by treatment with all-trans-retinoic acidA B Federici, A Falanga, A Lattuada, et al.
Blood|November 15, 1989
Heterogeneous phenotypes of platelet and plasma von Willebrand factor in obligatory heterozygotes for severe von Willebrand diseaseP M Mannucci, A Lattuada, G Castaman, et al.
Blood|August 15, 1989
Enhanced proteolysis of plasma von Willebrand factor in thrombotic thrombocytopenic purpura and the hemolytic uremic syndromeP M Mannucci, R Lombardi, A Lattuada, et al.
Circulation|September 12, 2000
Proteolysis of von Willebrand factor and shear stress-induced platelet aggregation in patients with aortic valve stenosisF I Pareti, A Lattuada, C Bressi, et al.
Blood|January 1, 1988
von Willebrand disease "Vicenza" with larger-than-normal (supranormal) von Willebrand factor multimersP M Mannucci, R Lombardi, G Castaman, et al.
HSR Proceedings in Intensive Care & Cardiovascular Anesthesia|February 27, 2013
Perioperative evaluation of primary hemostasis in patients undergoing mitral valve repairF Pappalardo, P Della Valle, G Maj, et al.
Pageof 6